Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 18.81
(9.49%)
CNY 18.81
(9.49%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.24 Billion CNY | 7.9% |
| 2022 | 2.08 Billion CNY | 3.84% |
| 2021 | 2 Billion CNY | 0.34% |
| 2020 | 2 Billion CNY | 36.4% |
| 2019 | 1.46 Billion CNY | 23.26% |
| 2018 | 1.18 Billion CNY | 13.61% |
| 2017 | 1.04 Billion CNY | 7.99% |
| 2016 | 969.85 Million CNY | 22.33% |
| 2015 | 792.83 Million CNY | 35.48% |
| 2014 | 585.19 Million CNY | -22.48% |
| 2013 | 754.9 Million CNY | 15.01% |
| 2012 | 656.39 Million CNY | 11.69% |
| 2011 | 587.71 Million CNY | 70.05% |
| 2010 | 345.61 Million CNY | 21.12% |
| 2009 | 285.35 Million CNY | 27.31% |
| 2008 | 224.13 Million CNY | 53.41% |
| 2007 | 146.1 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 647.76 Million CNY | 16.0% |
| 2024 Q1 | 533.19 Million CNY | -19.43% |
| 2024 Q2 | 558.43 Million CNY | 4.73% |
| 2023 Q4 | 661.79 Million CNY | 11.59% |
| 2023 FY | 2.24 Billion CNY | 7.9% |
| 2023 Q1 | 442.78 Million CNY | -27.11% |
| 2023 Q2 | 551.31 Million CNY | 24.51% |
| 2023 Q3 | 593.06 Million CNY | 7.57% |
| 2022 FY | 2.08 Billion CNY | 3.84% |
| 2022 Q4 | 607.48 Million CNY | 6.87% |
| 2022 Q3 | 568.42 Million CNY | 9.83% |
| 2022 Q2 | 517.53 Million CNY | 32.43% |
| 2022 Q1 | 390.8 Million CNY | -23.1% |
| 2021 Q3 | 458.23 Million CNY | -4.69% |
| 2021 Q4 | 508.19 Million CNY | 10.9% |
| 2021 Q2 | 480.79 Million CNY | -14.13% |
| 2021 FY | 2 Billion CNY | 0.34% |
| 2021 Q1 | 559.91 Million CNY | 3.86% |
| 2020 Q4 | 539.09 Million CNY | 0.39% |
| 2020 FY | 2 Billion CNY | 36.4% |
| 2020 Q1 | 453.92 Million CNY | 4.72% |
| 2020 Q2 | 470.4 Million CNY | 3.63% |
| 2020 Q3 | 536.98 Million CNY | 14.15% |
| 2019 Q1 | 307.41 Million CNY | -1.88% |
| 2019 Q4 | 433.45 Million CNY | 14.17% |
| 2019 FY | 1.46 Billion CNY | 23.26% |
| 2019 Q3 | 379.67 Million CNY | 9.72% |
| 2019 Q2 | 346.03 Million CNY | 12.56% |
| 2018 Q3 | 293.4 Million CNY | 1.63% |
| 2018 FY | 1.18 Billion CNY | 13.61% |
| 2018 Q1 | 294.46 Million CNY | -2.79% |
| 2018 Q2 | 288.69 Million CNY | -1.96% |
| 2018 Q4 | 313.3 Million CNY | 6.78% |
| 2017 Q4 | 302.91 Million CNY | 11.87% |
| 2017 FY | 1.04 Billion CNY | 7.99% |
| 2017 Q1 | 229.35 Million CNY | -13.08% |
| 2017 Q2 | 244.29 Million CNY | 6.51% |
| 2017 Q3 | 270.77 Million CNY | 10.84% |
| 2016 FY | 969.85 Million CNY | 22.33% |
| 2016 Q4 | 263.87 Million CNY | 3.12% |
| 2016 Q3 | 255.88 Million CNY | 7.03% |
| 2016 Q2 | 239.08 Million CNY | 13.3% |
| 2016 Q1 | 211.01 Million CNY | -12.48% |
| 2015 Q2 | 162.66 Million CNY | -5.59% |
| 2015 FY | 792.83 Million CNY | 35.48% |
| 2015 Q3 | 216.78 Million CNY | 33.27% |
| 2015 Q4 | 241.1 Million CNY | 11.22% |
| 2015 Q1 | 172.28 Million CNY | 27.64% |
| 2014 Q1 | 132.66 Million CNY | -39.39% |
| 2014 FY | 585.19 Million CNY | -22.48% |
| 2014 Q3 | 166.72 Million CNY | 10.55% |
| 2014 Q2 | 150.82 Million CNY | 13.68% |
| 2014 Q4 | 134.97 Million CNY | -19.04% |
| 2013 FY | 754.9 Million CNY | 15.01% |
| 2013 Q1 | 165.5 Million CNY | -11.9% |
| 2013 Q3 | 173.65 Million CNY | -11.79% |
| 2013 Q4 | 218.88 Million CNY | 26.04% |
| 2013 Q2 | 196.85 Million CNY | 18.94% |
| 2012 FY | 656.39 Million CNY | 11.69% |
| 2012 Q1 | 146.84 Million CNY | -6.6% |
| 2012 Q2 | 169.51 Million CNY | 15.44% |
| 2012 Q3 | 152.16 Million CNY | -10.23% |
| 2012 Q4 | 187.86 Million CNY | 23.46% |
| 2011 Q2 | 139.48 Million CNY | 7.02% |
| 2011 Q4 | 157.21 Million CNY | -2.15% |
| 2011 Q1 | 130.33 Million CNY | 25.15% |
| 2011 FY | 587.71 Million CNY | 70.05% |
| 2011 Q3 | 160.67 Million CNY | 15.19% |
| 2010 Q1 | 83.22 Million CNY | 2.27% |
| 2010 FY | 345.61 Million CNY | 21.12% |
| 2010 Q4 | 104.14 Million CNY | 26.49% |
| 2010 Q3 | 82.33 Million CNY | 8.46% |
| 2010 Q2 | 75.91 Million CNY | -8.78% |
| 2009 FY | 285.35 Million CNY | 27.31% |
| 2009 Q3 | 69.62 Million CNY | 0.0% |
| 2009 Q4 | 81.37 Million CNY | 16.87% |
| 2008 FY | 224.13 Million CNY | 53.41% |
| 2007 FY | 146.1 Million CNY | 0.0% |